Inventor · disambiguated record
Robert Alfonso Lasser
Also filed as: LASSER ROBERT A · LASSER ROBERT ALFONSO
0 granted patents·10 pending applications·0 citations·filing 2011–2024
Top patents by PatentIndex Score
10 records- 0179US2025339447A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0272US2022323462A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0359US2020113917A119-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0458US2021338692A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0558US2025295674A1Neuroactive steroids for treatment of cns-related disordersSAGE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0657US2024216396A1Neuroactive steroid for use in treating major depressive disorder and postpartum depression in a lactating femaleSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0754US2024245711A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid for the treatment of major depressive disorderSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0854US2024216395A119-nor c3,3-disubstituted c21 -n-pyrazolyl steroid for use in treating major depressive disorder and postpartum depressionSAGE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0950US2023018765A1A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereofSAGE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1030US2013217615A1Combination treatment of major depressive disorderLASSER ROBERT A·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Alfonso Lasser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →